"It ended up as the sound palette for a whole new generation": Inventor of FM synthesis John Chowning honoured with Technical Grammy Award

Chowning is a composer, musician and professor that had a seismic impact on both the development of music technology and the ...

Breakthrough Study Confirms HYD’s 30-Year Research on Deuterium Modulation in Cancer Gene Expression

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.

Evommune's EVO301 Phase 2a Data Drives 70% Stock Surge

Evommune surged 70% after EVO301's Phase 2a data showed rapid, significant EASI reductions in moderate-to-severe atopic ...
The Manila Times

MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer's Dise…

MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced ...
MusicRadar

“Offers power, warmth, charm and usability, in a highly convincing virtual analogue reproduction, with real heart and soul”: Cherry Audio SH-MAX review

Continuing its Japanese homage, Cherry Audio reignites three of Roland’s finest synths from the '70s, in a single soft-synth ...
TMCnet

IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY

OVATION 3 is IMUNON’s pivotal Phase 3 study of IMMN-001, an IL-12 gene-mediated immunotherapy, in women with advanced stage epithelial ovarian cancer. The study is supported with unprecedented overall ...

Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy

U.S. FDA Study May Proceed notification enables initiation of clinical trial site activation for the FUNCTION-DMD Phase 1/2 clinical study in patients with Duchenne muscular dystrophy (DMD) – – ...
Electronic Specifier

Mouser explores the challenges of powering AI in interactive eBook

Mouser Electronics announces a new Interactive eBook in collaboration with Renesas Electronics that explores how data centres ...
Pharmabiz

Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia

Sanofi’s rilzabrutinib receives US FDA breakthrough therapy & Japanese orphan drug designations to treat warm autoimmune haemolytic anaemia: Paris Wednesday, February 11, 2026, ...

K36 Therapeutics Completes Dosing of First Cohort in Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer, Announces New CMO

The Phase 1 clinical trial, STRIKE-001 (NCT07103018), is a multi-center, open-label dose escalation of KTX-2001 monotherapy (Part A) and in combination with darolutamide, an oral, nonsteroidal ...
Electronic Specifier

Innovations in millimetre-wave test instrumentation

Operating at millimetRE-wave frequencies introduces a set of engineering challenges that extend far beyond traditional radio frequency testing ...

Merry Life Biomedical Company, Ltd.: MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational ...

MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6 ...